Heward J, Konali L, D'Avola A, et al. KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas. Blood. 2021;138(5):370-381.

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC9461472 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature